Morphine: Patient Knowledge and Attitudes in the Central Anatolia Part of Turkey

dc.contributor.authorColak, Dilsen
dc.contributor.authorOguz, Arzu
dc.contributor.authorYazilitas, Dogan
dc.contributor.authorImmamoglu, Inanc Goksen
dc.contributor.authorAltinbas, Mustafa
dc.contributor.pubmedID24998575en_US
dc.date.accessioned2019-12-17T07:49:10Z
dc.date.available2019-12-17T07:49:10Z
dc.date.issued2014
dc.description.abstractBackground: In Muslim majority countries (MMC) opioid use for pain management is extremely low. The underlying factors contributing to this are not well defined. Aim: The aim of this study was to survey the attitudes of cancer patients towards morphine use for pain management in a MMC and identify the factors that influence patient decisions to accept or refuse morphine as treatment for cancer pain. Settings/participants: Patients were questioned whether they had pain or not, the severity and the medications for pain management. Questions included what type of medication they thought morphine was, whether or not they would be willing to take morphine if recommended for pain management and the basis for their decision if they were against morphine use. Results: Four hundred and eighty-eight patients participated in the study. Some 50% of the patients who refused morphine use and 36.8% of the patients who would prefer another drug, if possible, identified fear of addiction as the basis for their decision. Reservation of morphine for later in their disease was the case for 22.4% of the patients who refused morphine use. Only 13.7 % of the patients refusing morphine and 9.7% of the patients who preferred another drug, if possible, cited religious reasons as the basis for this decision. Conclusions: Identifying the underlying factors contributing to low opioid use for pain management in MMC is important. Once the underlying factors were identified, all efforts should be taken to overcome them as they are barriers to improving patient pain management.en_US
dc.identifier.endpage4988en_US
dc.identifier.issn1513-7368
dc.identifier.issue12en_US
dc.identifier.scopus2-s2.0-84904673827en_US
dc.identifier.startpage4983en_US
dc.identifier.urihttp://koreascience.or.kr/article/JAKO201424635095877.page
dc.identifier.urihttp://hdl.handle.net/11727/4460
dc.identifier.volume15en_US
dc.identifier.wos000343721800041en_US
dc.language.isoengen_US
dc.relation.isversionof10.7314/APJCP.2014.15.12.4983en_US
dc.relation.journalASIAN PACIFIC JOURNAL OF CANCER PREVENTIONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCanceren_US
dc.subjectmorphineen_US
dc.subjectpainen_US
dc.subjectMuslim countriesen_US
dc.titleMorphine: Patient Knowledge and Attitudes in the Central Anatolia Part of Turkeyen_US
dc.typearticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Risk_for_Malignant_and_Borderline_Ovarian_Neoplasms_Following_Basic_Preoperative_Evaluation_by_Ultrasonography,_Ca125_Level_and_Age.pdf
Size:
263.7 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: